Why did Teladoc stock fall today Amazon Clinic goes nationwide - Seeking Alpha
4LL Stock | EUR 9.02 0.34 3.92% |
Roughly 55% of Teladoc's stockholders are presently thinking to get in. The analysis of current outlook of investing in Teladoc suggests that some traders are interested regarding Teladoc's prospects. The current market sentiment, together with Teladoc's historical and current headlines, can help investors time the market. In addition, many technical investors use Teladoc stock news signals to limit their universe of possible portfolio assets.
Teladoc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Teladoc daily returns and investor perception about the current price of Teladoc as well as its diversification or hedging effects on your existing portfolios.
Teladoc |
Why did Teladoc stock fall today Amazon Clinic goes nationwide Seeking Alpha
Read at news.google.com
Teladoc Fundamental Analysis
We analyze Teladoc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Teladoc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Teladoc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Teladoc is rated fourth in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Teladoc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Teladoc stock to make a market-neutral strategy. Peer analysis of Teladoc could also be used in its relative valuation, which is a method of valuing Teladoc by comparing valuation metrics with similar companies.
Peers
Teladoc Related Equities
4LL | Teladoc | 3.92 | ||||
9EH | Evolent Health | 3.88 | ||||
2HE | Healthequity | 1.69 | ||||
COPA | COMPUGROUP MEDSPADR | 0.97 | ||||
1KJ | 10X GENOMICS | 0.56 | ||||
COP | CompuGroup Medical | 0.28 | ||||
3CM | RLX TECH | 0.54 | ||||
COP | Compugroup Medical | 0.64 | ||||
VEE | Veeva Systems | 2.16 | ||||
1XZ | Ping An | 2.60 |
Complementary Tools for Teladoc Stock analysis
When running Teladoc's price analysis, check to measure Teladoc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teladoc is operating at the current time. Most of Teladoc's value examination focuses on studying past and present price action to predict the probability of Teladoc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teladoc's price. Additionally, you may evaluate how the addition of Teladoc to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |